Latest filing published 23 Jun 2026 for BeOne Medicines Ltd., €260k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Lai Wang: trading record in brief
All filings by Lai Wang on record concern BeOne Medicines Ltd. In total, 4 filings cover trades dated from 8 June 2026 to 23 June 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 23 June 2026 came the latest disclosure, a transaction for €260k in BeOne Medicines Ltd. The median gap between trade and publication is zero days: most filings appear on the same day. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Lai Wang
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,068 shares@ US$276.7350.0010% mcap100.0% of flowADSSEC144:0001950047-26-006417
- 1,169 shares@ US$265.3857ADSSEC144:0001950047-26-006183
- 756 shares@ US$261.415ADSSEC144:0001950047-26-005951
3 of 3 declarations
